Medical Aesthetic Patient Population Is Getting Younger

AAFPRS Annual Member Survey

The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) has released the results of its 2019 annual member survey on aesthetic procedures. Overall, facial plastic surgery procedures increased 6 percent last year compared to 2018, and demand for nonsurgical aesthetic procedures is up 13 percent compared to 2018. And the patients seeking these procedures are younger than in years past.

New Studies Move Topical Minocycline Foam for Rosacea Closer To Approval

Topical Minocycline Foam for Rosacea

Two phase 3 studies of Foamix Pharmaceuticals’ FMX103 (minocycline, 1.5% foam) were published in the Journal of the American Academy of Dermatology (online January 26). Foamix conducted FX2016-11 and FX2016-12 (Studies 11 & 12) to support the New Drug Application (NDA) submission of FMX103, which is currently under review by the U.S. Food and Drug Administration (FDA) for the treatment of moderate-to-severe papulopustular rosacea in adults.

FDA Sets PDUFA Date for Revance DAXI Neuromodulator

Revance Therapeutics

The United States Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for Revance Therapeutics’ DaxibotulinumtoxinA for Injection (DAXI) in the treatment of moderate to severe glabellar (frown) lines. In a press release issued by Revance, the company noted that, in its correspondence, the FDA stated that no potential filing review issues were identified and indicated in the BLA filing communication letter that it is not currently planning to hold an advisory committee meeting to discuss the application.

Candela Launches Exceed Microneedling System in U.S.

Candela To Commercialize MT.DERM Systems

Candela Corporation is now offering the Exceed Microneedling device for the treatment of wrinkles and facial acne scars. The company recently entered into an exclusive collaboration agreement with MT.DERM GmbH for the commercialization of its medical microneedling products. Under the terms of the agreement, Candela will commercialize the Exceed medical microneedling system globally, with an initial launch in the United States. The agreement may be expanded with additional products in the future.

Allergan Launches JUVEDERM Lips Consumer Campaign


Allergan is launching a new direct-to-consumer campaign for JUVÉDERM Lips. Centered around self-expression, the campaign kicks off on February 11 with ads and creative deploying across TV, social media and digital advertising. Board-certified plastic surgeon Dara Liotta, MD, reality television personality Audrina Patridge and celebrity makeup artist Kelsey Deenihan will share how and why they choose JUVÉDERM as their lip filler brand of choice.

InMode Launches Evolve Hands-Free Workstation

Noninvasive Body and Face Workstation

InMode has launched, Evolve, a noninvasive hands-free workstation designed to remodel skin, treat adipose tissue and tone muscles. The Evolve delivers bipolar radiofrequency and electromagnetic pulses to treat skin and subdermal fat and improve muscle tone. Providers can use the workstation to perform Tite, Trim and/or Tone treatments, each of which can be customized to the patient’s needs.

Tillemans Takes Helm as CEO of Cynosure

Todd Tillemans, a global business leader with 30 years of experience in personal care, beauty, food and beverage, is the new CEO of Cynosure, LLC. Tillemans is the former president of Hershey's flagship U.S. business generating over $6.5 billion in annual sales. Prior to that, he held various leadership positions across Unilever’s skin and personal care portfolio where he helped build global personal care brands, including Dove, Axe, Vaseline, Ponds and Degree.